Needlestick injuries in European nurses in diabetes.
OBJECTIVE
With the June 2010 publication of EU Council Directive 2010/32/EU scrutiny is now being focused on the safety and protection of diabetes nurses.


METHODS
We used a questionnaire to study the frequency and risks of Needlestick Injuries (NSI) associated with diabetic injections in European hospitals. 634 nurses participated from 13 western European countries and Russia.


RESULTS
When patients with diabetes who self-inject at home are hospitalized injections are given always by the staff in 31% of cases, by the patients themselves where possible in 33%, initially by staff, then the patient takes over in 12% and both staff and patient throughout the stay in 21%. 86% of nurses said their hospitals had a written policy on the prevention of NSI but, where it was available, only 56% were familiar with it. 67% of the nurses had not attended any training on the prevention of NSI and only 13% had attended one in the last year. 7.1% of nurses report recapping needles and 5.9% report storing unprotected needles temporarily on a tray, trolley or cart. 32% of nurses report suffering a NSI while giving a diabetic injection at some point in the past. 29.5% of NSI occurred while recapping a used needle. 57% of nurses unscrew pen needles using their own fingers. In 80% cases the source patient's identity was known and the sharp item was "contaminated" (known previous percutaneous exposure to patient) in almost half the cases (43%). NSIs were reported to the proper authorities in only 2/3 of cases.


CONCLUSIONS
Our study shows that frequent NSI occur in European nurses treating people with diabetes in hospital settings. These injuries are a source of possible infection despite the small size of diabetes needles. The introduction of safety-engineered medical devices has been shown to reduce the risk of injury. A new European Directive that has now come into force specifically stipulates that wherever there is risk of sharps injury, the user and all healthcare workers must be protected by adequate safety precautions, including the use of "medical devices incorporating safety-engineered protection mechanisms".
European Medical Association, Brussels, Belgium.
V
V
Costigliola
A
A
Frid
C
C
Letondeur
K
K
Strauss
D000062:Accidents, Occupational / Q000517:prevention & control / Q000706:statistics & numerical data; D003920:Diabetes Mellitus; D005060:Europe / Q000453:epidemiology; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission*; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission*; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control* / Q000706:statistics & numerical data; D016602:Needlestick Injuries / Q000453:epidemiology / Q000517:prevention & control*; D009726:Nurses; D060051:Occupational Injuries / Q000453:epidemiology / Q000517:prevention & control*; D012426:Russia / Q000453:epidemiology; D011795:Surveys and Questionnaires